Displaying 1 - 12 of 35
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Medscape Education Global: Primary Biliary Cholangitis: Setting Higher Expectations (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: Nuances in treatment decisions for PBC management (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Amgen: Mitigating the Impact of IgG4-Related Cholangitis (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Meet the Experts in Cholestatic Liver Disease (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Adult Cholestatic Liver Disease: Focusing on Clinical Outcomes and the Future of IBAT Inhibitors (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC: Innovative Solutions for Today’s Challenges (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: The Spectrum of Genetic Cholestasis: The Critical Role of Early Diagnosis and Treatment for Adult Patients (Complete Se...

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Displaying 1 - 12 of 35